Scott Solomon, MD

About

Book an Appointment with Scott Solomon, MD

New Patient Existing Patient

Scott Solomon, MD received his medical degree from the University of Colorado Health Sciences Center in Denver, Colorado. His residency in Internal Medicine was served at the University of Kansas Medical Center in Kansas City, Kansas. Following residency, Dr. Solomon was selected by the Internal Medicine Faculty to serve as Chief Resident in the Department of Internal Medicine. During his Chief Residency year, he held a faculty appointment as an Instructor of Internal Medicine at the University of Kansas Medical Center.  Dr. Solomon completed his Cardiovascular Disease Fellowship at Mid America Heart Institute in Kansas City, Missouri and completed his Interventional Cardiology Fellowship at St. Louis University, St. Louis, Missouri. He performs most heart procedures through the radial artery in the wrist.  His areas of special interest include Interventional Cardiology, peripheral vascular disease and General Cardiology. He is Board Certified in Internal Medicine and Cardiovascular Disease. Dr. Solomon enjoys spending time with his family and fishing.

Research/Publications

1. Solomon, C.S. and Goalstone, M.L. Dominant negative alpha-subunit of Ftase inhibits effects of insulin and IGF-1 in MCF-7 cells. Biochemical and Biophysical Research Communications. 2001 Mar; 291(3): 458-465.
2. Chappell, J., Leitner, J.W., Solomon, C.S., Golovchenko, I., Goalstone, M.L., and Draznin, B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells: direct and potentiating influence. Journal of Biological Chemistry. 2001 Oct; 276(41): 38023-8.
3. Solomon, C.S. and Goalstone, M.L. Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects. Biochemical and Biophysical Research Communications. 2002 Jul; 285(2): 161-166.
4. Solomon, C.S., Leitner, J.W., Goalstone, M.L. Dominant negative alpha-subunit of farnesyl- and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes. International Journal of Obesity Related Metabolic Disorders. 2003 Jan; 27(1): 40-47.
5. Solomon S, Barnes B, Howard P, Kumar A, Chen W, Vacek JL. The impact of Omega-3 fatty acid use on the risk of atrial fibrillation in patients with cardiovascular disease. International Journal Clinical Medicine. 2011 Feb; 2(1): 23-27.
6. Barnes B, Solomon, S, Howard P, Lakkireddy D, Kramer J, Muehlebach G, Daon E, Zorn G, Vacek J. Preoperative Statin use is not Associated with a Reduced Risk of Atrial Fibrillation after Cardiac Surgery. Journal of Atrial Fibrillation. 2011 May; 2(5): 891.
7. Solomon S, Vacek JL. Invited article: Practice Pearls. Reducing cardiac ischemic events in patients with ACS: prasugrel versus clopidogrel. Commentary. Postgrad Med. 2010 Jan; 122(1):198-200.
8. Solomon, S, Thompson, R. Role of coronary artery calcium scoring in the patient with a normal SPECT, A review. Current Cardiovascular Imaging Reports. 2012 June; 5(3): 173-178.